These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 5778630)
21. The clinical use of monthly injectable contraceptive preparations. Toppozada M Obstet Gynecol Surv; 1977 Jun; 32(6):335-47. PubMed ID: 865726 [No Abstract] [Full Text] [Related]
22. [Medroxyprogesterone acetate administered intramuscularly every third month as a contraceptive. An investigation of the efficacy, side effects and acceptability]. Marker IL Ugeskr Laeger; 1973 Feb; 135(6):294-7. PubMed ID: 4690434 [No Abstract] [Full Text] [Related]
23. Parenteral medroxyprogesterone as a contraceptive agent. Scutchfield FD; Long WN Public Health Rep (1896); 1969 Dec; 84(12):1059-62. PubMed ID: 4982071 [No Abstract] [Full Text] [Related]
25. [Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent]. Linthorst G; Wibaut EP; de Jongh RE Ned Tijdschr Geneeskd; 1972 Sep; 116(38):1694-8. PubMed ID: 5069858 [No Abstract] [Full Text] [Related]
26. Statement on injectable contraception. Revised. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1992 Dec; 26(6):4-6. PubMed ID: 12346921 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of deladroxate as a monthly contraceptive injection. Karim M; El-mahgoub S; El-ganzoury B; Ammar R; Yaseen S; Fikri F Ain Shams Med J; 1971 May; 22(3):343-7. PubMed ID: 12264799 [TBL] [Abstract][Full Text] [Related]
28. [Use of a long-term contraceptive of semestral application. Preliminary report]. Rubio Lotvin B; Ruiz Moreno JA; Bolio Arista R; González Ansorena R Ginecol Obstet Mex; 1973 Jun; 33(200):595-601. PubMed ID: 4732314 [No Abstract] [Full Text] [Related]
29. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Brenner P Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246 [No Abstract] [Full Text] [Related]
30. Community-based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation. Stanback J; Spieler J; Shah I; Finger WR; Contraception; 2010 Mar; 81(3):181-4. PubMed ID: 20159172 [No Abstract] [Full Text] [Related]
31. [Medroxprogestrone acetate as a contraceptive]. Hornemann B; Osler M Ugeskr Laeger; 1973 Feb; 135(6):289-94. PubMed ID: 4690433 [No Abstract] [Full Text] [Related]
32. Fertility control with long-acting injectable steroids. A preliminary report. Zañartu J; Rice-Wray E; Goldzieher JW Obstet Gynecol; 1966 Oct; 28(4):513-5. PubMed ID: 5925038 [No Abstract] [Full Text] [Related]
33. [Contraception with the 3-months injection]. Hauser GA Ther Umsch; 1972 May; 29(5):310-3. PubMed ID: 5064704 [No Abstract] [Full Text] [Related]
34. American Academy of Pediatrics: Committee on Drugs. Medroxyprogesterone acetate (Depo-Provera). Pediatrics; 1980 Jan; 65(1):A74. PubMed ID: 7355001 [No Abstract] [Full Text] [Related]
37. Controlled trial with a monthly combination injectable contraceptive in Europe. Brucker C Gynecol Endocrinol; 2001 Aug; 15 Suppl 3():11-4. PubMed ID: 11570312 [TBL] [Abstract][Full Text] [Related]
38. DELADROXATE FOR THE PREVENTION OF OVULATION. RUTHERFORD RN; BANKS AL; COBURN WA Fertil Steril; 1964; 15():648-52. PubMed ID: 14236841 [No Abstract] [Full Text] [Related]
39. Why are US women not using long-acting contraceptives? Tanfer K; Wierzbicki S; Payn B Fam Plann Perspect; 2000; 32(4):176-83, 191. PubMed ID: 10942353 [TBL] [Abstract][Full Text] [Related]
40. The contraceptive patch in relation to ischemic stroke and acute myocardial infarction. Jick SS; Jick H Pharmacotherapy; 2007 Feb; 27(2):218-20. PubMed ID: 17253912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]